These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 3857396

  • 1. A clinical evaluation of carbohydrate antigen 19-9 and carcinoembryonic antigen in patients with pancreatic carcinoma.
    Satake K, Kanazawa G, Kho I, Chung YS, Umeyama K.
    J Surg Oncol; 1985 May; 29(1):15-21. PubMed ID: 3857396
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of serum pancreatic enzymes, carbohydrate antigen 19-9, and carcinoembryonic antigen in various pancreatic diseases.
    Satake K, Kanazawa G, Kho I, Chung Y, Umeyama K.
    Am J Gastroenterol; 1985 Aug; 80(8):630-6. PubMed ID: 2411125
    [Abstract] [Full Text] [Related]

  • 3. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
    Lorenz M, Happ J, Hottenrott C, Maul FD, Baum RP, Hör G, Encke A.
    Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
    [Abstract] [Full Text] [Related]

  • 4. Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases.
    Kuusela P, Jalanko H, Roberts P, Sipponen P, Mecklin JP, Pitkänen R, Mäkelä O.
    Br J Cancer; 1984 Feb; 49(2):135-9. PubMed ID: 6582896
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of CA 72-4 with CA 19-9 and carcinoembryonic antigen in the serodiagnostics of gastrointestinal malignancies.
    Heptner G, Domschke S, Domschke W.
    Scand J Gastroenterol; 1989 Aug; 24(6):745-50. PubMed ID: 2814339
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Assay of serum carbohydrate antigen (CA) 19-9 in the diagnosis of gastric cancer].
    Nishida K, Yamamoto T, Yoshioka K, Iida M, Miyagawa H, Yoshikawa T, Sugino S, Kondo M.
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):101-8. PubMed ID: 3455804
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases.
    Kuusela P, Haglund C, Roberts PJ, Jalanko H.
    Br J Cancer; 1987 Jun; 55(6):673-6. PubMed ID: 2441731
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical value of CA 19-9 (carbohydrate antigen) in gastrointestinal adenocarcinoma.
    Mennini G, Silecchia G, Zanna C, Cucchiara G, Spadaro G, Greco E, Basoli A, Speranza V.
    Ital J Surg Sci; 1985 Jun; 15(1):37-43. PubMed ID: 3858272
    [Abstract] [Full Text] [Related]

  • 19. Comparative effectiveness of the tumour diagnostics, CA 19-9, CA 125 and carcinoembryonic antigen in patients with diseases of the digestive system.
    Sakamoto K, Haga Y, Yoshimura R, Egami H, Yokoyama Y, Akagi M.
    Gut; 1987 Mar; 28(3):323-9. PubMed ID: 3471687
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.